OT-82

N/A

Report date: 2024/11/22 20:00:28
NME

Base Information

Drug NameOT-82
Drug Alias NameOT-82
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNicotinamide phosphoribosyltransferase inhibitors
TargetsNicotinamide phosphoribosyltransferase
Therapy Area/IndicationsLymphoma, T-Cell, PeripheralLymphoma, T-CellLymphoma, Follicular +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOncotartis Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOncotartis Inc
Active IndicationsN/A
Inactive IndicationsLymphoma, T-Cell, PeripheralLymphoma, T-CellLymphoma, Follicular +[7] 

Other Information

ATC CodeN/A
Related LinksN/A